News
BEAT
0.4310
+6.97%
0.0281
HeartBeam says redirecting resources to myocardial infarction detection
TipRanks · 1d ago
Weekly Report: what happened at BEAT last week (0914-0918)?
Weekly Report · 1d ago
HeartBeam, Inc. Letter to Shareholders
Barchart · 1d ago
Weekly Report: what happened at BEAT last week (0907-0911)?
Weekly Report · 09/14 10:06
Weekly Report: what happened at BEAT last week (0831-0904)?
Weekly Report · 09/07 10:00
Weekly Report: what happened at BEAT last week (0824-0828)?
Weekly Report · 08/31 10:06
Weekly Report: what happened at BEAT last week (0817-0821)?
Weekly Report · 08/24 10:07
HeartBeam Earnings Call: Fast Trials, Slow Revenue Build
TipRanks · 08/22 00:27
HeartBeam Buy Rating Reiterated as Clinical and Commercial Momentum Strengthens; $2 Price Target Maintained
TipRanks · 08/18 16:55
Weekly Report: what happened at BEAT last week (0810-0814)?
Weekly Report · 08/17 10:07
HeartBeam Launches New At-The-Market Equity Offering
TipRanks · 08/14 21:28
HeartBeam Enters ATM Equity Offering Agreement To Sell Up To $25M Of Common Stock Through Titan Partners Securities
Benzinga · 08/14 21:07
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 08/14 17:06
Analysts Offer Insights on Healthcare Companies: Icecure Medical (ICCM) and HeartBeam (BEAT)
TipRanks · 08/14 11:50
HeartBeam GAAP EPS of -$0.10 misses by $0.01
Seeking Alpha · 08/13 20:06
*Heartbeam 2Q Loss/Shr 10c >BEAT
Dow Jones · 08/13 20:01
*Heartbeam 2Q Loss $5.04M >BEAT
Dow Jones · 08/13 20:01
Weekly Report: what happened at BEAT last week (0803-0807)?
Weekly Report · 08/10 10:03
HeartBeam Shareholders Shape Governance, Reject Equity Plan Expansion
TipRanks · 08/03 21:03
Weekly Report: what happened at BEAT last week (0727-0731)?
Weekly Report · 08/03 10:03
More
Webull provides a variety of real-time BEAT stock news. You can receive the latest news about Heartbeam Inc through multiple platforms. This information may help you make smarter investment decisions.
About BEAT
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.